Table 1 Demographics of COVID-19, influenza and dengue patients.

From: Differentiating coronavirus disease 2019 (COVID-19) from influenza and dengue

 

COVID-19

(N = 126)

Influenza

(N = 171)

P-value

Dengue

(N = 180)

P-value

Age, median (IQR)

52 (37–62)

30 (22–40)

 < 0.0005

36 (29–43)

 < 0.0005

Male, n (%)

74 (58.7)

98 (57.3)

0.813

153 (85.0)

 < 0.0005

Co-morbidity^, n (%)

26 (20.6)

31 (18.1)

0.655

18 (10.0)

0.012

Diabetes

15 (11.9)

1 (0.6)

 < 0.0005

1 (0.6)

 < 0.0005

Chronic obstructive pulmonary disease (COPD)/Asthma

4 (3.2)

8 (4.7)

0.569

0 (0.0)

0.027

Myocardial infarction

7 (5.6)

–

–

1 (0.6)

0.009

Malignancies

2 (1.6)

–

–

0 (0.0)

0.167

Chronic liver disease

1 (0.8)

–

–

0 (0.0)

0.410

Chronic renal disease

1 (0.8)

–

–

0 (0.0)

0.410

  1. IQR interquartile range, ‘- ‘ indicates data is not available.
  2. All P values shown are for comparison with COVID-19, based on Fisher’s exact test for categorical variables and Mann–Whitney U test for continuous variables.
  3. ^None of the COVID-19 and dengue patients had congestive heart failure, peripheral vascular disease, stroke or dementia, while these comorbid conditions were not recorded for influenza patients.
Back to article page